Managing Obesity in Survivors of Gynecologic Cancer

Allison Staley, MD, MPH
Published: Saturday, May 25, 2019
Staley, MD, MPH

Allison Staley, MD, MPH

Obesity influences the development and management of gynecologic cancer through several mechanisms, including hormonal, inflammatory, and metabolic pathways. Prospective data demonstrate a significantly increased risk of mortality from cancers of the breast, uterus, cervix, and ovary in women who are considered obese.1 With nearly 40% of the adult population in the Unites States classified as obese (body mass index [BMI] ≥30kg/m2), gynecologic oncologists must be ready to address the specific needs and considerations for this population, including for patients who have entered survivorship.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication